Skip to main content
. 2022 Sep 20;9(6):4335–4339. doi: 10.1002/ehf2.14165

Figure 2.

Figure 2

Technetium‐99m pyrophosphate (99mTc‐PYP) scintigraphy at baseline (A and B) and 1 year after tafamidis treatment (C and D).